Home|DSIJArticleDetail

Pharma Penny Stock Under Rs 60: Company Set For Bold Expansion; To Add 1000 Medical Representatives
Pharma Penny Stock Under Rs 60: Company Set For Bold Expansion; To Add 1000 Medical Representatives

Pharma Penny Stock Under Rs 60: Company Set For Bold Expansion; To Add 1000 Medical Representatives

The company has a market cap of over Rs 2,750 crore and the stock is up over 20 per cent from its 52-week low of Rs 41.66 per share

DSIJ Intelligence-1 Article rating: 3.4

The company has a market cap of over Rs 2,750 crore and the stock is up over 20 per cent from its 52-week low of Rs 41.66 per share

Stock under Rs 25: Add this stock to your watchlist as it gets green signal from USFDA
Stock under Rs 25: Add this stock to your watchlist as it gets green signal from USFDA

Stock under Rs 25: Add this stock to your watchlist as it gets green signal from USFDA

Market participants are advised to keep the stock on their watchlist for Monday.

DSIJ Intelligence-3 Article rating: 3.9

Going forward, the 16800 mark is expected to act as strong support for the index, and traders are advised to keep a close watch on this level. In addition, market participants should also keep an eye on the stock of

Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!
Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!

Top gaining stocks: These healthcare stocks surged over 10 per cent despite a sharp decline in domestic markets!

The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.

DSIJ Intelligence-1 Article rating: 4.3

The only sector which was least affected today was the BSE Healthcare Index, which plunged 1.18 per cent to Rs 23,493.96, despite a sharp decline in the domestic market.

DSIJ MINDSHARE

Mkt Commentary25-Apr, 2025

Penny Stocks25-Apr, 2025

Bonus and Spilt Shares25-Apr, 2025

Mindshare25-Apr, 2025

Bonus and Spilt Shares25-Apr, 2025

Knowledge

MF22-Apr, 2025

MF17-Apr, 2025

General22-Mar, 2025

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered and Correspondence Office Address :
DSIJ PVT LTD. Office No - 409,
Solitaire Business Hub, Kalyani Nagar, Pune - 411006
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList